TrademarkOpen
Search / United States / 97887331

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

CELLDEX

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for…
Show more

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 17 Apr 2023
    Application filed
    New Application Entered
  2. 9 Jan 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 9 Jan 2024
    Approved for publication
    Approved For Pub - Principal Register
  4. 13 Feb 2024
    Published for opposition
    Published For Opposition
  5. 9 Apr 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 11 Nov 2024
    Application abandoned — no statement of use filed
    Abandonment - No Use Statement Filed
  7. 12 Jun 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 12 Jun 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  9. 4 Sep 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 43 events
2026-04-04Notice Of Approval Of Extension Request E-Mailed
2026-04-03Sou Teas Extension Received
2026-04-03Sou Extension 4 Filed
2026-04-03Sou Extension 4 Granted
2026-01-16Applicant/Correspondence Changes (Non-Responsive) Entered
2025-12-03Teas Post Publication Amendment Received
2025-09-15Notice Of Approval Of Extension Request E-Mailed
2025-09-04Sou Teas Extension Received
2025-09-04Sou Extension 3 Filed
2025-09-04Sou Extension 3 Granted
2025-07-10Teas Post Publication Amendment Received
2025-07-10Amendment After Noa Not Entered
2025-06-13Notice Of Approval Of Extension Request E-Mailed
2025-06-13Notice Of Approval Of Extension Request E-Mailed
2025-06-12Sou Extension 1 Granted
2025-06-12Sou Extension 2 Granted
2025-06-09Case Assigned To Intent To Use Paralegal
2025-05-12Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-05-12Attorney/Dom.rep.revoked And/Or Appointed
2025-05-12Teas Change Of Correspondence Received
2025-05-06Teas Petition To Revive Received
2025-05-06Petition To Revive-Granted
2025-05-06Notice Of Revival - E-Mailed
2025-05-06Sou Extension Received With Teas Petition
2025-04-08Sou Extension 2 Filed
2024-11-11Abandonment - No Use Statement Filed
2024-11-11Abandonment Notice Mailed - No Use Statement Filed
2024-10-08Sou Extension 1 Filed
2024-04-09Noa Mailed - Sou Required From Applicant
2024-02-13Published For Opposition
2024-02-13Official Gazette Publication Confirmation E-Mailed
2024-01-24Notification Of Notice Of Publication E-Mailed
2024-01-09Assigned To Examiner
2024-01-09Approved For Pub - Principal Register
2023-09-26Assigned To Lie
2023-09-26Applicant/Correspondence Changes (Non-Responsive) Entered
2023-09-26Preliminary/Voluntary Amendment - Entered
2023-05-08New Application Office Supplied Data Entered
2023-05-05Teas Voluntary Amendment Received
2023-04-18Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2023-04-18Attorney/Dom.rep.revoked And/Or Appointed
2023-04-18Teas Change Of Correspondence Received
2023-04-17New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 5 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.